Central Nervous System Manifestations in Systemic Lupus Erythematosus

被引:3
作者
Appenzeller, Simone [1 ,2 ]
Lavras Costallat, Lilian Tereza [1 ]
Cendes, Fernando [2 ,3 ]
机构
[1] Univ Estadual Campinas, Rheumatol Unit, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Neuroimaging Lab, Campinas, SP, Brazil
[3] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
CNS involvement; SLE;
D O I
10.2174/157339707781387572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurologists and rheumatologist are often called to evaluate central nervous system (CNS) manifestations in patients with suspected or definite systemic lupus erythematosus (SLE). The manifestations are highly diverse and often have major prognostic consequences. The major difficulties are to determine if the given manifestation is primarily due to SLE activity in the brain, or a consequence of metabolic disturbances, infection, or corticosteroid use. The true incidence of CNS manifestations attributable to SLE is not entirely clear, but several studies show prevalence rate between 15-75%, depending on different methods and classification criteria applied. This paper has the objective to review the main clinical manifestations according to American College of Rheumatology (ACR) criteria, possible etiological mechanisms and neuroimaging features associated with these manifestations. We further discuss the most important tools that can help bedside diagnosis.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 138 条
[91]   Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort [J].
Mikdashi, J ;
Handwerger, B .
RHEUMATOLOGY, 2004, 43 (12) :1555-1560
[92]   Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study [J].
Mok, CC ;
Lau, CS ;
Wong, RWS .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01) :59-62
[93]  
Mok CC, 1998, J RHEUMATOL, V25, P467
[94]  
Mok CC, 2001, J RHEUMATOL, V28, P766
[95]  
MOORE PM, 1997, RHEUM EUR0PE, V26, P36
[96]   Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus [J].
Moritani, T ;
Shrier, DA ;
Numaguchi, Y ;
Takahashi, C ;
Yang, T .
ACADEMIC RADIOLOGY, 2001, 8 (08) :741-753
[97]   SELECTIVE IMPAIRMENT OF LEARNING AND BLOCKADE OF LONG-TERM POTENTIATION BY AN N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST, AP5 [J].
MORRIS, RGM ;
ANDERSON, E ;
LYNCH, GS ;
BAUDRY, M .
NATURE, 1986, 319 (6056) :774-776
[98]   ROLE OF INTRAVENOUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF SEVERE NEUROPSYCHIATRIC SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
NEUWELT, CM ;
LACKS, S ;
KAYE, BR ;
ELLMAN, JB ;
BORENSTEIN, DG .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (01) :32-41
[99]  
NOSSENT JC, 1991, ARTHRITIS RHEUM-US, V34, P1397
[100]   Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement [J].
Oku, K ;
Atsumi, T ;
Furukawa, S ;
Horita, T ;
Sakai, Y ;
Jodo, S ;
Amasaki, Y ;
Ichikawa, K ;
Amengual, O ;
Koike, T .
RHEUMATOLOGY, 2003, 42 (06) :773-777